The Antibody Fragments Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Antibody Fragments Market?
The market size of antibody fragments has seen substantial growth in recent years. It is set to increase from $10.35 billion in 2024 to $11.37 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Antibody Fragments Industry?
The Antibody Fragments Global Market Report 2025 predicts that by 2029, the market will reach a size of $16.44 billion, growing at a compound annual growth rate (CAGR) of 9.6%.
Download Your Free Sample of the 2025 Antibody Fragments Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Antibody Fragments Market?
The key drivers in the Antibody Fragments market are:
• Increased investment in research and development in the biologics sector
• Growing preference for smaller antibody formats
• Rising demand for personalized medicine
• Expansion of applications in autoimmune diseases
Global Market Segmentation: Identifying Major Antibody Fragments Industry Segments
The antibody fragments market covered in this report is segmented –
1) By Type: F(ab) Fragments, F(ab’)2 Fragments, Single-Chain Variable Fragments (scFvs), Single Domain Antibody Fragments (sdAbs), Other Types
2) By Specificity: Monoclonal Antibody, Polyclonal Antibody
3) By Delivery Method: Intravenous (IV), Subcutaneous (SC), Oral, Transdermal
4) By Application: Cancer, Immunodeficiencies, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Diagnostic Laboratories, Contract Research Organizations (CROs)
Pre-order the 2025 Antibody Fragments Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Antibody Fragments Market?
The key trends in the Antibody Fragments market are:
• Integration of AI-driven drug discovery is a major upcoming trend in the antibody fragments market.
• Development of cost-effective production methods is shaping the future of the market.
• Collaborations between biotech firms form a significant trend.
• The market will likely be influenced by advancements in monoclonal antibody technology and the focus on antibody-drug conjugates.
Who Are the Top Competitors & Leading Players in the Antibody Fragments Market?
Major companies in the Antibody Fragments market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche AG
• AbbVie Inc.
• Sanofi S.A.
• AstraZeneca PLC
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• UCB S.A.
• Bio-Rad Laboratories Inc.
• Genmab A/S
• WuXi Biologics Co. Ltd.
• Abcam plc
• MacroGenics Inc.
• Harbour BioMed
• Creative Biolabs Inc.
Regional Dominance: Which Area Leads the Global Antibody Fragments Market?
North America was the largest region in the antibody fragments market in 2024
